Cargando…

Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases

The liver, the largest organ with multiple synthetic and secretory functions in mammals, consists of hepatocytes, cholangiocytes, hepatic stellate cells (HSCs), sinusoidal endothelial cells, Kupffer cells (KCs), and immune cells, among others. Various causative factors, including viral infection, to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Chenxia, Zhao, Lingfei, Li, Lanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613269/ https://www.ncbi.nlm.nih.gov/pubmed/31287024 http://dx.doi.org/10.1186/s13287-019-1310-1

Ejemplares similares

Transplantation of mesenchymal stem cells and their derivatives effectively promotes liver regeneration to attenuate acetaminophen-induced liver injury
por: Hu, Chenxia, et al.
Publicado: (2020)

Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis
por: Hu, Chenxia, et al.
Publicado: (2019)

Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury
por: Hu, Chenxia, et al.
Publicado: (2020)

Modulating autophagy in mesenchymal stem cells effectively protects against hypoxia- or ischemia-induced injury
por: Hu, Chenxia, et al.
Publicado: (2019)

Regulation of the mitochondrial reactive oxygen species: Strategies to control mesenchymal stem cell fates ex vivo and in vivo
por: Hu, Chenxia, et al.
Publicado: (2018)

Pre‐treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases
por: Hu, Chenxia, et al.
Publicado: (2019)

Porcine Adipose-Derived Mesenchymal Stem Cells Retain Their Stem Cell Characteristics and Cell Activities While Enhancing the Expression of Liver-Specific Genes after Acute Liver Failure
por: Hu, Chenxia, et al.
Publicado: (2016)

Melatonin preconditioning is an effective strategy for mesenchymal stem cell‐based therapy for kidney disease
por: Zhao, Lingfei, et al.
Publicado: (2019)

The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation
por: Hu, Chenxia, et al.
Publicado: (2019)

Regulation of autophagy protects against liver injury in liver surgery‐induced ischaemia/reperfusion
por: Hu, Chenxia, et al.
Publicado: (2021)

In vitro culture of isolated primary hepatocytes and stem cell-derived hepatocyte-like cells for liver regeneration
por: Hu, Chenxia, et al.
Publicado: (2015)

Protective role of melatonin in early‐stage and end‐stage liver cirrhosis
por: Hu, Chenxia, et al.
Publicado: (2019)

Melatonin plays critical role in mesenchymal stem cell-based regenerative medicine in vitro and in vivo
por: Hu, Chenxia, et al.
Publicado: (2019)

Preconditioning influences mesenchymal stem cell properties in vitro and in vivo
por: Hu, Chenxia, et al.
Publicado: (2018)

Autophagy regulation is an effective strategy to improve the prognosis of chemically induced acute liver injury based on experimental studies
por: Hu, Chenxia, et al.
Publicado: (2020)

Mesenchymal stem cell therapy targeting mitochondrial dysfunction in acute kidney injury
por: Zhao, Lingfei, et al.
Publicado: (2019)

In Vitro and In Vivo Hepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver Diseases
por: Hu, Chenxia, et al.
Publicado: (2015)

Mesenchymal stromal cells promote liver regeneration through regulation of immune cells
por: Hu, Chenxia, et al.
Publicado: (2020)

Current understanding of mesenchymal stem cells in liver diseases
por: Wu, Mu-Chen, et al.
Publicado: (2021)

The application of resveratrol to mesenchymal stromal cell-based regenerative medicine
por: Hu, Chenxia, et al.
Publicado: (2019)

A pooled analysis of mesenchymal stem cell-based therapy for liver disease
por: Zhao, Lu, et al.
Publicado: (2018)

Serum ammonia is a strong prognostic factor for patients with acute-on-chronic liver failure
por: Hu, Chenxia, et al.
Publicado: (2020)

Melatonin and its protective role in attenuating warm or cold hepatic ischaemia/reperfusion injury
por: Hu, Chenxia, et al.
Publicado: (2021)

Novel preconditioning strategies for enhancing the migratory ability of mesenchymal stem cells in acute kidney injury
por: Zhao, Lingfei, et al.
Publicado: (2018)

Interaction between Mesenchymal Stem Cells and B-Cells
por: Fan, Linxiao, et al.
Publicado: (2016)

Preconditioning strategies for improving the survival rate and paracrine ability of mesenchymal stem cells in acute kidney injury
por: Zhao, Lingfei, et al.
Publicado: (2018)

Preconditioning is an effective strategy for improving the efficiency of mesenchymal stem cells in kidney transplantation
por: Zhao, Lingfei, et al.
Publicado: (2020)

Mesenchymal Stem Cell-Based Therapy for Stroke: Current Understanding and Challenges
por: Li, Weifeng, et al.
Publicado: (2021)

The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future
por: Zhang, Sainan, et al.
Publicado: (2020)

Regenerative abilities of mesenchymal stem cells via acting as an ideal vehicle for subcellular component delivery in acute kidney injury
por: Zhao, Lingfei, et al.
Publicado: (2020)

Cytokines in adipose-derived mesenchymal stem cells promote the healing of liver disease
por: Nahar, Saifun, et al.
Publicado: (2018)

Genetic communication by extracellular vesicles is an important mechanism underlying stem cell-based therapy-mediated protection against acute kidney injury
por: Zhao, Lingfei, et al.
Publicado: (2019)

Cellular senescence, a novel therapeutic target for mesenchymal stem cells in acute kidney injury
por: Zhao, Lingfei, et al.
Publicado: (2020)

Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: a review with a focus on preclinical models
por: Zhao, Lingfei, et al.
Publicado: (2019)

Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease
por: Yuan, Mengqin, et al.
Publicado: (2022)

Promotion Effects of miR-375 on the Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells
por: Chen, Si, et al.
Publicado: (2017)

Noninvasive in-vivo tracing and imaging of transplanted stem cells for liver regeneration
por: Cen, Panpan, et al.
Publicado: (2016)

Recent Advances of Adipose-Tissue-Derived Mesenchymal Stem Cell-Based Therapy for Retinal Diseases
por: Finocchio, Lucia, et al.
Publicado: (2023)

Pre‐conditions for eliminating mitochondrial dysfunction and maintaining liver function after hepatic ischaemia reperfusion
por: Hu, Chenxia, et al.
Publicado: (2017)

Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives
por: Harrell, C. Randall, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g4uu9t9415ka2phcitr9oh3ldb